Fiduciary Family Office’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Sell
655
-51
-7% -$17.5K 0.06% 164
2026
Q1
$248K Buy
706
+45
+7% +$16K 0.07% 162
2025
Q4
$216K Buy
+661
New +$210K 0.06% 178
2025
Q2
Sell
-691
Closed -$215K 189
2025
Q1
$215K Buy
+691
New +$204K 0.07% 178

Other funds holding AMGN

Fiduciary Family Office's AMGN Position: Q2 2026 in Review

Fiduciary Family Office reduced its Amgen (AMGN) stake by 7.2% in Q2 2026, selling an estimated $17.5K and leaving 655 shares worth $237K. The position accounts for 0.06% of the portfolio, ranked #164.

Fiduciary Family Office first reported a position in AMGN in Q1 2025 and has held it in 4 quarters since. The position peaked at $248K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fiduciary Family Office held 655 shares of Amgen worth $237K as of Q2 2026.
  • Fiduciary Family Office sold 51 Amgen shares in Q2 2026, an estimated $17.5K.
  • Amgen made up 0.06% of Fiduciary Family Office's portfolio in Q2 2026, its #164 holding.
  • Fiduciary Family Office first reported a position in Amgen in Q1 2025 and has held it in 4 quarters since.
  • Fiduciary Family Office's Amgen position peaked at $248K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fiduciary Family Office's 13F filing for Q2 2026, filed 5 Aug 2026.